Lijie Huang
- Neurology top 5%
- Intracerebral and Subarachnoid Hemorrhage Research 6
- Cancer Research top 5%
- Cancer-related molecular mechanisms research 10
- MicroRNA in disease regulation 5
- Developmental Neuroscience top 5%
- Biological Psychiatry top 10%
- Neurology top 10%
- Intracerebral and Subarachnoid Hemorrhage Research 6
-
- Glioma Diagnosis and Treatment 5
-
- RNA modifications and cancer 5
- Inflammasome and immune disorders 5
- Circular RNAs in diseases 5
-
- Immune cells in cancer 5
- Journals
- CNS Neuroscience & Therapeutics (3 papers)Progress in Neurobiology (2 papers)Molecules (2 papers)
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Lijie Huang
62 papers receiving 1.7k citations
Peers
Comparison fields: 5 of 129
- Neurology 193
- Cancer Research 333
- Developmental Neuroscience 75
- Biological Psychiatry 39
- Neurology 191
Countries citing papers authored by Lijie Huang
This map shows the geographic impact of Lijie Huang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lijie Huang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lijie Huang more than expected).
Fields of papers citing papers by Lijie Huang
This network shows the impact of papers produced by Lijie Huang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lijie Huang. The network helps show where Lijie Huang may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Lijie Huang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 1 | |
| 2 | 2024 | 1 | |
| 3 | 2024 | 2 | |
| 4 | 2024 | 14 | |
| 5 | 2024 | 24 | |
| 6 | 2024 | 5 | |
| 7 | 2024 | 13 | |
| 8 | 2023 | 0 | |
| 9 | 2023 | 19 | |
| 10 | 2021 | 43 | |
| 11 | 2021 | 24 | |
| 12 | 2021 | 4 | |
| 13 | 2020 | 24 | |
| 14 | 2020 | 92 | |
| 15 | 2020 | 21 | |
| 16 | 2020 | 78 | |
| 17 | 2019 | 32 | |
| 18 | 2018 | 8 | |
| 19 | 2014 | 177 | |
| 20 | Study on MF-RO combined membranes process in concentrating grosvenori infusion | 2009 | 0 |
About Lijie Huang
Lijie Huang is a scholar working on Cancer Research, Neurology and Genetics, having authored 66 papers that have together received 1.7k indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (10 papers), Intracerebral and Subarachnoid Hemorrhage Research (6 papers), Glioma Diagnosis and Treatment (5 papers), RNA modifications and cancer (5 papers), MicroRNA in disease regulation (5 papers), Inflammasome and immune disorders (5 papers), Circular RNAs in diseases (5 papers) and Immune cells in cancer (5 papers). The work is most often cited by research in Neurology (193 citations), Cancer Research (333 citations) and Developmental Neuroscience (75 citations). Lijie Huang has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Qichuan Zhuge, Kunlin Jin, Su Yang, Xiao Lin, Felix Siaw-Debrah, Haoqi Ni, Junnan Ru, Kankai Wang, Leidong Mao and Bo Yang. Their work appears in journals such as CNS Neuroscience & Therapeutics, Progress in Neurobiology, Molecules, Cancer Letters and World Journal of Surgical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.